531 related articles for article (PubMed ID: 14606264)
1. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
2. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
3. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
Foroumadi A; Soltani F; Asadipour A
Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
[TBL] [Abstract][Full Text] [Related]
4. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
5. Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex.
Heifets LB; Iseman MD; Lindholm-Levy PJ
Drugs Exp Clin Res; 1987; 13(9):529-38. PubMed ID: 3428133
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives.
Sriram D; Yogeeswari P; Basha JS; Radha DR; Nagaraja V
Bioorg Med Chem; 2005 Oct; 13(20):5774-8. PubMed ID: 16039859
[TBL] [Abstract][Full Text] [Related]
9. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
Foroumadi A; Soltani F; Mirzaei M
Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054
[TBL] [Abstract][Full Text] [Related]
10. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
Tsukamura M
Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
12. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
[TBL] [Abstract][Full Text] [Related]
14. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
17. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Bhusal Y; Shiohira CM; Yamane N
Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of 3-hydrazono-1H-2-indolinones with antituberculosis activity.
Karah N; Terzioĝlu N; Gürsoy A
Arzneimittelforschung; 1998 Jul; 48(7):758-63. PubMed ID: 9706377
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]